Narayana Hrudayalaya Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
November 10, 2021 at 08:43 am EST
Share
Narayana Hrudayalaya Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 9,402.79 million compared to INR 6,007.29 million a year ago. Revenue was INR 9,524.13 million compared to INR 6,111.42 million a year ago. Net income was INR 993.37 million compared to net loss of INR 34.22 million a year ago. Basic earnings per share from continuing operations was INR 4.89 compared to basic loss per share from continuing operations of INR 0.17 a year ago. Diluted earnings per share from continuing operations was INR 4.89 compared to diluted loss per share from continuing operations of INR 0.17 a year ago.
For the six months, sales was INR 18,000.77 million compared to INR 9,942.29 million a year ago. Revenue was INR 18,188.92 million compared to INR 10,092.94 million a year ago. Net income was INR 1,755.17 million compared to net loss of INR 1,231.27 million a year ago. Basic earnings per share from continuing operations was INR 8.65 compared to basic loss per share from continuing operations of INR 6.07 a year ago. Diluted earnings per share from continuing operations was INR 8.64 compared to diluted loss per share from continuing operations of INR 6.07 a year ago.
Narayana Hrudayalaya Limited is an India-based healthcare service provider, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. The Company owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology - oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation and infectious diseases. The Company has a network of approximately 19 hospitals and three heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.